Data Year:

For its 2024 fiscal year, UNITEDHEALTH GROUP INC, listed the following executives on its annual proxy statement to the SEC

Equity
Cash Compensation
Other
Fiscal Year Ended in 2024
Name And Title Total Compensation Pay Rank By Title In Insurance industry
Andrew Witty
Chief Executive Officer
Total Compensation $26,339,215 View details Pay Rank By Title In Insurance industry #6 View more
Brian Thompson
Former Executive Vice President and CEO, UnitedHealthcare
Total Compensation $8,985,520 View details Pay Rank By Title In Insurance industry #61 View more
John Rex
President and CFO
Total Compensation $18,731,183 View details Pay Rank By Title In Insurance industry #2 View more
Christopher Zaetta
Executive Vice President, Chief Legal Officer and Corporate Secretary
Total Compensation $6,873,295 View details Pay Rank By Title In Insurance industry #2 View more
Erin McSweeney
Executive Vice President and Chief People Officer
Total Compensation $6,268,428 View details Pay Rank By Title In Insurance industry #17 View more
Heather Cianfrocco
Executive Vice President and CEO, Optum
Total Compensation $11,449,467 View details Pay Rank By Title In Insurance industry #2 View more

The charts on this page feature a breakdown of the total annual pay for the top executives at UNITEDHEALTH GROUP INC as reported in their proxy statements.

Total Cash Compensation information is comprised of yearly Base Pay and Bonuses. UNITEDHEALTH GROUP INC income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. UNITEDHEALTH GROUP INC annual reports of executive compensation and pay are most commonly found in the Def 14a documents.

Total Equity aggregates grant date fair value of stock and option awards and long term incentives granted during the fiscal year.

Other Compensation covers all compensation-like awards that don't fit in any of these other standard categories. Numbers reported do not include change in pension value and non-qualified deferred compensation earnings.

Name And Title Total Cash Equity Other Total Compensation
Andrew Witty
Chief Executive Officer
Total Cash $3,000,000 Equity $23,000,118 Other $339,097 $26,339,215
Brian Thompson
Former Executive Vice President and CEO, UnitedHealthcare
Total Cash $961,539 Equity $8,000,622 Other $23,359 $8,985,520
John Rex
President and CFO
Total Cash $3,442,308 Equity $15,000,946 Other $287,929 $18,731,183
Christopher Zaetta
Executive Vice President, Chief Legal Officer and Corporate Secretary
Total Cash $1,638,077 Equity $5,001,066 Other $234,152 $6,873,295
Erin McSweeney
Executive Vice President and Chief People Officer
Total Cash $1,625,000 Equity $4,500,593 Other $142,835 $6,268,428
Heather Cianfrocco
Executive Vice President and CEO, Optum
Total Cash $2,500,000 Equity $8,001,432 Other $948,035 $11,449,467
For its 2024 fiscal year, UNITEDHEALTH GROUP INC, listed the following CEO pay ratio data on its annual proxy statement to the SEC.
CEO Name CEO Pay Median Employee Pay CEO Pay Ratio
Andrew Witty CEO Pay $26,356,446 Median Employee Pay $75,778 CEO Pay Ratio 348:1
For its 2024 fiscal year, UNITEDHEALTH GROUP INC, listed the following board members on its annual proxy statement to the SEC.
Name Total COMPENSATION
Charles Baker Total Cash $366,072
F. William McNabb, III Total Cash $393,602
John Noseworthy, M.D. Total Cash $390,756
Kristen Gil Total Cash $514,769
Michele Hooper Total Cash $441,349
Paul Garcia Total Cash $366,567
Stephen Hemsley Total Cash $856,218
Timothy Flynn Total Cash $400,765
Valerie Montgomery Rice, M.D. Total Cash $424,262
Browse Board of Directors By First Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Browse Executives by First Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Browse Companies by Company Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

This report is not for commercial use. Thorough reviews have been conducted to assure this data accurately reflects disclosures. However for a complete and definitive understanding of the pay practices of any company, users should refer directly to the actual, complete proxy statement.

Use of Data / Disclaimer

The information shown here is a reporting of information included in the company's proxy statement. The proxy statement includes footnotes and explanations of this information plus other information that is pertinent in assessing the overall value and appropriateness of the compensation information. For those interested in conducting a detailed compensation analysis, we recommend that you review the entire proxy statement. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov and entering the company's name and then looking in the first column for an entry of "Form DEF 14A" (or any similar code). You may also find the annual proxy statement by going directly to the company's website.

What is a proxy statement?

A proxy statement (or "proxy") is a form that every publicly traded U.S. company is required to file with the U.S. Securities & Exchange Commission (SEC) within 120 days after the end of its fiscal year. The proxy must be sent to every shareholder in advance of the company's annual shareholders meeting. All proxy statements are public filings made available to the general public by the SEC.

The proxy statement's main purpose is to alert shareholders to the annual meeting and provide them information about the issues that will be voted on during the annual meeting, including decisions such as electing directors, ratifying the selection of auditors, and other shareholder-related decisions, including shareholder-initiated initiatives. Also, proxies must disclose specific detailed information regarding the pay practices for certain executives.